An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease Spectrum
Clinical trial NCT02406027 · TERMINATED
Trial details
- NCT number
- NCT02406027
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-02
- Primary completion
- 2018-06-28
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.